Litcius/Paper detail

The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich’s ataxia

Shannon Chiang, Danuta S. Kalinowski, Mahendiran Dharmasivam, Nady Braidy, Des R. Richardson, Michael Huang

2020Pharmacological Research10 citationsDOIOpen Access PDF

Topics & Concepts

NAD+ kinaseFrataxinBioenergeticsMitochondrionPharmacologyCardiomyopathyChemistryBiochemistryBiologyInternal medicineEndocrinologyMedicineHeart failureAconitaseEnzymeGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyAutophagy in Disease and Therapy
The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich’s ataxia | Litcius